Related Experiment Video

Updated: Jul 11, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Fighting cancer with plant-expressed pharmaceuticals

Merardo Pujol1, Jorge Gavilondo, Marta Ayala

  • 1Plant Division, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, C.P. 10600, Havana, Cuba. merardo.pujol@cigb.edu.cu

Trends in Biotechnology
|September 18, 2007
PubMed

Insights

Plant-based systems offer a promising, cost-effective method for producing anti-cancer biological therapies. This review explores recent advancements in expressing anti-cancer proteins in plants, addressing technical challenges and future potential.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer remains a leading global health concern, driving demand for effective biological therapies.
  • Recombinant pharmaceuticals are crucial, with anti-cancer drugs forming a significant market share.
  • Current production methods for recombinant pharmaceuticals face limitations, including challenges with microbial and mammalian cell cultures.

Purpose of the Study:

  • To review recent advancements in the plant-based production of anti-cancer recombinant pharmaceuticals.
  • To discuss the technical aspects, potential, and future prospects of using plants for pharmaceutical manufacturing.
  • To highlight the advantages of plant-based systems over traditional methods.

Main Methods:

  • Literature review of recent publications on plant-expressed anti-cancer pharmaceuticals.
  • Analysis of technical challenges and solutions in plant-based biopharmaceutical production.
  • Evaluation of the economic and scalability factors of plant expression systems.

Main Results:

  • Plants are emerging as a viable system for producing recombinant anti-cancer proteins.
  • Plant-based production offers potential cost reductions and simplified scaling compared to cell cultures.
  • Recent studies demonstrate progress in overcoming technical hurdles in plant expression.

Conclusions:

  • Plant-based expression systems represent a promising frontier for the cost-effective production of anti-cancer biological therapies.
  • Further research and development are needed to optimize yields and streamline processes for commercial viability.
  • The transition to plant-based manufacturing could significantly impact the accessibility and affordability of cancer treatments.

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...